Our pipeline
Our promising pipeline is based on innovative drug delivery systems and proven APIs, and is designed to address medical unmet needs advised by internationally renowned KOLs.
Our product candidates could ensure a full compliance of the patient while drastically reducing or even eliminating side effects and avoiding degradation of the pathology.
-
Feasibility
-
Pre-clinical
-
Clinical
Phase I -
Clinical
Phase II -
Clinical
Phase III -
Regular
Approval
-
TimoD
GlaucomaClinical Phase I
-
BimatoD
GlaucomaFeasibility
-
HydraD
Dry eyePre-Clinical
-
InflammaD
Back of the eyeFeasibility
TimoD clinical Phase 1 :
- https://clinicaltrials.gov/study/NCT06321562
- https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-511254-51-00
EyeD Pharma’s unique value proposal relies on a fully integrated approach, from idea to market.
We manage the entire development process from idea to market including product development, non-clinical & clinical studies. Our development, clinical and commercial batches are produced on our internally developed specific production process.